Dialysis News and Research

Latest Dialysis News and Research

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Watson Pharmaceuticals, Inc. today announced that it is initiating launch activities of Nulecit, following FDA approval of GeneraMedix Inc.'s, Abbreviated New Drug Application.

1 Apr 2011

Bipartisan senate bill would set process to review future Medicare provider cuts

The measure would bar any cuts from taking place before the Health and Human Services secretary determines they are necessary. Meanwhile, in other Medicare news, ProPublica reports that federal regulators are in the process of making kidney dialysis clinic data more accessible to the public.

31 Mar 2011

Lupus nephritis ESRD study finds increase in incidence rates among children, African Americans

New research documenting changes in the incidence and outcomes of end-stage renal disease in the U.S. between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans.

28 Mar 2011

Tengion 2010 adjusted net loss decreases to $25.8 million

Tengion, Inc. today provided a business update and reported its financial results for the year ended December 31, 2010.

25 Mar 2011

Contention continues a year later

News outlets remark on the continuing ferocity of the health overhaul debate — even a year later — as its advocates and detractors continue efforts to advance or block the measure's implementation.

25 Mar 2011

Immune system misinterprets threats and attacks body's own cells and tissue

Many chronic diseases are the result of the body's immune system mistakenly perceiving that the body is under attack from foreign bodies. A counterattack is then launched - an inflammatory response meant to vanquish the intruder. In reality, the immune system has misinterpreted the threat and is actually attacking the body's own cells and tissue.

24 Mar 2011

Affymax, Takeda's peginesatide Phase 3 data in dialysis patient to be presented at NKF meeting

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced multiple posters on peginesatide have been accepted for presentation at the National Kidney Foundation 2011 Spring Clinical Meeting taking place April 26-30, 2011 in Las Vegas, Nevada.

24 Mar 2011

First continuous-flow total artificial heart transplant performed at THI

Doctors at the Texas Heart Institute at St. Luke's Episcopal Hospital have successfully implanted the first continuous-flow total artificial heart in a desperately ill patient facing imminent death.

24 Mar 2011

Researchers review patient outcomes from full, partial organ removal for kidney cancer

Patients with kidney cancer who had their entire organ removed were more likely to have more renal complications and poorer health after surgery, compared to those who had only part of their kidney removed, a study has shown.

19 Mar 2011

ANCI signs agreement with Annapolis for healthcare solution

American CareSource Holdings, Inc., the nation's leading ancillary health care network services company, announced today that it has signed and implemented an agreement with Annapolis, Maryland-based Self Funding Administrators Corporation, a third party administrator representing an additional 30,000 covered lives.

18 Mar 2011

Study: Daily hemodialysis can help alleviate sleep problems related to RLS

For dialysis patients, performing daily dialysis at home can help alleviate sleep problems related to restless legs syndrome, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

18 Mar 2011

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.

18 Mar 2011

FDA grants CSI marketing clearance for Stealth 360° Orbital PAD System

Cardiovascular Systems, Inc. has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA), and has begun a limited market release for the Stealth 360°™ Orbital PAD System. The Stealth 360° propels CSI into the forefront of treating peripheral arterial disease (PAD) with a simpler design that gives physicians complete control of device operation.

17 Mar 2011

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

A UC Irvine infectious disease specialist will be part of a nationwide Centers for Disease Control and Prevention research program to develop and test innovative approaches to reducing infection in healthcare settings.

17 Mar 2011

New study on how epoxyeicosatrienoic acids protect kidneys

Researchers at Georgia Health Sciences University are studying whether inhibiting an enzyme that reduces levels of a protective metabolite could halt the progression of diabetic nephropathy, or kidney disease resulting from diabetes.

16 Mar 2011

Argon acquires global rights to market, distribute Rex Medical's Option Retrievable Inferior Vena Cava Filter

Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP ("Rex Medical") for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).

15 Mar 2011

DaVita enhances company's governance policies and practices

The Board of Directors of DaVita Inc. today announced that it has enhanced the company's already strong corporate governance policies and practices.

14 Mar 2011

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Diabetes and high blood pressure are the two leading causes of chronic kidney disease, a health problem that is growing at an alarming rate in the United States. There are 26 million Americans who have CKD, and millions more are at increased risk and may not even know it.

11 Mar 2011

Seattle Children's Hospital inaugurates new dialysis unit

Today, timed with World Kidney Day, Seattle Children's Hospital announced the opening of its newly renovated dialysis unit. The unit will significantly improve patient comfort and safety compared to its predecessor facility, and includes an additional 630 square feet of space for a total of nearly 2,400 square feet.

11 Mar 2011

Depression is linked with increased risk of developing kidney failure

Depression is associated with an increased risk of developing kidney failure in the future, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

10 Mar 2011

Dialysis News and Research

Latest Dialysis News and Research

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Bipartisan senate bill would set process to review future Medicare provider cuts

Lupus nephritis ESRD study finds increase in incidence rates among children, African Americans

Tengion 2010 adjusted net loss decreases to $25.8 million

Contention continues a year later

Immune system misinterprets threats and attacks body's own cells and tissue

Affymax, Takeda's peginesatide Phase 3 data in dialysis patient to be presented at NKF meeting

First continuous-flow total artificial heart transplant performed at THI

Researchers review patient outcomes from full, partial organ removal for kidney cancer

ANCI signs agreement with Annapolis for healthcare solution

Study: Daily hemodialysis can help alleviate sleep problems related to RLS

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FDA grants CSI marketing clearance for Stealth 360° Orbital PAD System

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

New study on how epoxyeicosatrienoic acids protect kidneys

Argon acquires global rights to market, distribute Rex Medical's Option Retrievable Inferior Vena Cava Filter

DaVita enhances company's governance policies and practices

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Seattle Children's Hospital inaugurates new dialysis unit

Depression is linked with increased risk of developing kidney failure

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in